| | | |   | | | | By Ed Silverman Drew Angerer/Getty Images The legislation seeks to clarify the extent to which pharmaceutical companies are entitled to monopolies on orphan drugs. Read More | | By Damian Garde Getty Images for Gabrielle's Angel Foundation Seagen, the $22 billion company Siegall co-founded in 1997, said he had taken a leave of absence sixteen days after the incident. Read More | | By Adam Feuerstein SEBASTIEN BOZON/AFP via Getty Images The outcome is a significant blow to the Swiss pharma giant’s effort to develop the most important cancer drug in its research pipeline. Read More | | Sponsor content by STAT TRIALS PULSE How a biotech startup is using AI tools to redefine how they approach clinical development Artificial Intelligence is transforming the way small biotechs are scaling their businesses. In our latest case study of Feldan Therapeutics, we show how STAT Trials Pulse has become a game-changer for them, helping accelerate data-gathering, better analyze their competitors, and streamline their operations. Read the case. | | By Allison DeAngelis Adobe Biotech veteran Alexis Borisy and entrepreneur Zach Weinberg are homing in on independent founders, rather than starting biotechs themselves. Read More | |
No comments